InvestorsHub Logo
Followers 94
Posts 11294
Boards Moderated 0
Alias Born 11/02/2003

Re: None

Tuesday, 12/04/2018 8:48:42 AM

Tuesday, December 04, 2018 8:48:42 AM

Post# of 2833
NEWS -- Actinium Pharmaceuticals Highlights Analysis of Pivotal Iomab-B Phase 3 SIERRA Trial Presented in Oral Session at ASH Annual Meeting

https://ih.advfn.com/p.php?pid=nmona&article=78815612&symbol=ATNM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News